Reply to “Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population”

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
JournalAnnals of Neurology
Volume87
Early online date1 Nov 2019
DOIs
Publication statusPublished - 1 Jan 2020

Cite this

@article{1d9f1a2a0ee54b78a7448362456d1c72,
title = "Reply to “Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population”",
author = "Verberk, {Inge M. W.} and Teunissen, {Charlotte E.} and {van der Flier}, {Wiesje. M.}",
year = "2020",
month = "1",
day = "1",
doi = "10.1002/ana.25633",
language = "English",
volume = "87",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Reply to “Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population”

AU - Verberk, Inge M. W.

AU - Teunissen, Charlotte E.

AU - van der Flier, Wiesje. M.

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075066718&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31675120

U2 - 10.1002/ana.25633

DO - 10.1002/ana.25633

M3 - Comment/Letter to the editor

VL - 87

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

ER -